(Q39380205)

11 September 2017

title

Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements (English)

1 reference

11 September 2017

0 references

E F P M Vuurman

1

1 reference

11 September 2017

G H Rikken

2

1 reference

11 September 2017

N D Muntjewerff

3

1 reference

11 September 2017

F de Halleux

4

1 reference

11 September 2017

J G Ramaekers

5

1 reference

11 September 2017

publication date

28 May 2004

1 reference

European Journal of Clinical Pharmacology

11 September 2017

published in

1 reference

11 September 2017

volume

60

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

307-313

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0757-9

11 September 2017

exact match

0 references

cites work

Clinical pharmacology of new histamine H1 receptor antagonists

1 reference

12 December 2020

Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers.

1 reference

12 December 2020

Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance

1 reference

12 December 2020

Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

1 reference

12 December 2020

Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving

1 reference

12 December 2020

Quantification of Sleepiness: A New Approach

1 reference

12 December 2020

Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis.

1 reference

12 December 2020

Desloratadine demonstrates dose proportionality in healthy adults after single doses

1 reference

12 December 2020

Effects of mefloquine alone and with alcohol on psychomotor and driving performance.

1 reference

12 December 2020

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

1 reference

12 December 2020

Specific review of the psychometric effects of cetirizine.

1 reference

12 December 2020

Antihistamines and driving safety.

1 reference

12 December 2020

Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment

1 reference

12 December 2020

Impact of sedating antihistamines on safety and productivity.

1 reference

12 December 2020

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

1 reference

12 December 2020

Diazepam impairs lateral position control in highway driving.

1 reference

12 December 2020

A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic

1 reference

12 December 2020

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

1 reference

12 December 2020

H1-receptor antagonists: safety issues

1 reference

12 December 2020

24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

1 reference

12 December 2020

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects

1 reference

12 December 2020

Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance: A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator

1 reference

12 December 2020

Effects of seasonal allergic rhinitis on selected cognitive abilities

1 reference

12 December 2020

10.1007/S00228-004-0757-9

Identifiers

DOI

1 reference

11 September 2017

1 reference